Related Experiment Video
Updated: Feb 9, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds
1Section on Clinical Pharmacology, National Institute of Mental Health, Bethesda, Maryland 20892.
Abstract:
The acute and chronic pharmacotherapy of bipolar disorder requires an understanding of the pharmacology of very dissimilar compounds--the mood stabilizers (lithium, carbamazepine and valproate) and several classes of antidepressants. No definitive data are available on the primary mode of action of mood stabilizers, and those used show no single pharmacological property. On the other hand, the pharmacokinetics and dynamics of these compounds are well studied.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Related Concept Videos
Bipolar Disorder
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Ethical Issues
Ethical Concerns in Healthcare:
Traits, Mood, and Subjective Wellbeing
Neuroticism and...
Nuclear Stability
To hold positively charged protons together...
Bipolar Junction Transistor